Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HNO International (HNOI) Research & Development (2022 - 2024)

HNO International filings provide 3 years of Research & Development readings, the most recent being $5901.0 for Q1 2024.

  • On a quarterly basis, Research & Development rose 6384.62% to $5901.0 in Q1 2024 year-over-year; TTM through Jan 2024 was $45132.0, a N/A change, with the full-year FY2023 number at $43049.0, down 18.65% from a year prior.
  • Research & Development hit $5901.0 in Q1 2024 for HNO International, down from $24138.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $24138.0 in Q4 2023 to a low of $91.0 in Q1 2023.
  • Median Research & Development over the past 3 years was $10451.5 (2023), compared with a mean of $10865.3.
  • Biggest five-year swings in Research & Development: fell 12.41% in 2023 and later skyrocketed 6384.62% in 2024.
  • HNO International's Research & Development stood at $2933.0 in 2022, then surged by 722.98% to $24138.0 in 2023, then tumbled by 75.55% to $5901.0 in 2024.
  • The last three reported values for Research & Development were $5901.0 (Q1 2024), $24138.0 (Q4 2023), and $15002.0 (Q3 2023) per Business Quant data.